Chorea, benign familial

Summary

Chorea, benign familial (MONDO:0008979) is a disease. A subtype of choreatic disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	chorea, benign familial
Mondo ID	MONDO:0008979
MeSH	C565851
OMIM	215450
UMLS	C1859098
MedGen	347799
GARD	0001305
Is cancer (heuristic)	no

Also known as: benign hereditary chorea · chorea familial benign · chorea, benign familial

Disease family

This is a subtype of choreatic disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › movement disorder › choreatic disease › chorea, benign familial

Related subtypes (4): chorea gravidarum, choreoathetosis, familial inverted, chorea, remitting, with nystagmus and cataract, hereditary progressive chorea without dementia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.